Back to CVE records
High 8.3Published Oct 11, 2026

CVE-2026-108522Studio-Saelix Sencho Login Endpoint login improper authentication

Updated under an hour ago ()

Does this affect you?

It affects Studio-Saelix Sencho. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.42%, higher than 35% of scored CVEs.

A vulnerability was found in Studio-Saelix Sencho up to 0.94.1. This affects an unknown part of the file /api/auth/login of the component Login Endpoint. Performing a manipulation of the argument X-Forwarded-For results in improper authentication. The attack is possible to be carried out remotely. The exploit has been made public and could be used. The patch is named 79b86ddcd4aefdd6941f098e35990ab397b13c72. To fix this issue, it is recommended to deploy a patch. The vendor confirms: "The login limiter relied on client-supplied X-Forwarded-For data without an explicit trusted-proxy boundary, allowing an attacker to rotate the apparent client address. The remediation now ignores forwarding headers by default, accepts them only from explicitly configured proxy CIDRs, and adds a separate failed-attempt limit keyed by normalized account identity."

CVSS
8.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L/E:P/RL:O/RC:C
Weakness (CWE)
CWE-287
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.42% (percentile 35)
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Oct 14, 2026
First seen by InfoSec Signals
Oct 11, 2026

Affected products

Affected products
Studio-Saelix Sencho
studio-saelix:sencho
0.94.0; 0.94.1
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit
  • issue-tracking, patch
  • patch
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.